Stock Events

Stock Events

Bristol-Myers Squibb 

$62.27
9075
-$0.42-0.67%Wednesday 08:30

Statistics

Day High
62.44
Day Low
61.32
52W High
63.22
52W Low
54
Volume
20,262
Avg. Volume
-
Mkt Cap
127.29B
P/E Ratio
-
Dividend Yield
4.05%
Dividend
2.52

Upcoming

Dividends

4.05%Dividend Yield
Nov 2026
$0.63
Aug 2026
$0.63
May 2026
$0.63
Feb 2026
$0.63
Nov 2025
$0.62
10Y Growth
5.19%
5Y Growth
5.15%
3Y Growth
3.39%
1Y Growth
1.61%

Earnings

Feb 4Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
1.1
1.41
1.73
2.04
Expected EPS
1.522109
Actual EPS
N/A

Financials

14.64%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
48.19BRevenue
7.05BNet Income

Analyst Ratings

$65.23Average Price Target
The highest estimate is ⁦78.00⁩.
From 13 ratings within the last 6 months. This is not an investment recommendation.
Buy
46%
Hold
46%
Sell
8%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BMY.BOATS. It's not an investment recommendation.
Realty Income
2390
O
Apple
2007
AAPL
Coca-Cola
2005
KO
Johnson & Johnson
1963
JNJ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer competes directly in various therapeutic areas including oncology, immunology, and cardiovascular diseases.
Merck
MRK
Mkt Cap368.89B
Merck & Co. is a key competitor in the pharmaceutical industry, especially in the oncology segment with its blockbuster cancer drug Keytruda.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson competes across multiple segments including pharmaceuticals, with a strong presence in immunology and oncology.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes in areas like immunology and oncology, directly challenging Bristol-Myers Squibb's product lineup.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline competes in the pharmaceutical and healthcare sector, with a focus on respiratory diseases, HIV, and vaccines.
Novartis
NVS
Mkt Cap303.67B
Novartis is a global healthcare company that competes in various therapeutic areas including cardiovascular, oncology, and immunology.
AMGEN
AMGN
Mkt Cap251.94B
Amgen competes in the biopharmaceutical sector, focusing on human therapeutics, including treatments for cancer and cardiovascular disease.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes in the global pharmaceutical market, with a focus on diabetes, oncology, and rare diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, with a strong emphasis on oncology and immunology.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca is a global, science-led biopharmaceutical business that competes in core areas of healthcare, including oncology, cardiovascular, renal, and metabolism.

About

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Show More
CEO
ISIN
US1101221083

Listings

STU
DE
BRM.STU
XETRA
DE
BRM.XETRA
BA
AR
BMY.BA
SA
BR
BMYB34.SA

0 Comments

Share your thoughts

FAQs

What is Bristol-Myers Squibb stock price today?▼
The current price of BMY.BOATS is $62.27 USD — it has decreased by -0.67% in the past 24 hours. Watch Bristol-Myers Squibb stock price performance more closely on the chart.
What is Bristol-Myers Squibb stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Bristol-Myers Squibb stocks are traded under the ticker BMY.BOATS.
What is Bristol-Myers Squibb market cap?▼
Today Bristol-Myers Squibb has the market capitalization of 127.29B
When is the next Bristol-Myers Squibb earnings date?▼
Bristol-Myers Squibb is going to release the next earnings report on February 4, 2027.
What were Bristol-Myers Squibb earnings last quarter?▼
BMY.BOATS earnings for the last quarter are 1.35 USD per share, whereas the estimation was 1.1 USD resulting in a +22.86% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bristol-Myers Squibb revenue for the last year?▼
Bristol-Myers Squibb revenue for the last year amounts to 48.19B USD.
What is Bristol-Myers Squibb net income for the last year?▼
BMY.BOATS net income for the last year is 7.05B USD.
Does Bristol-Myers Squibb pay dividends?▼
Yes, BMY.BOATS dividends are paid quarterly. The last dividend per share was 0.63 . As of today, Dividend Yield (FWD)% is 4.05%.
In which sector is Bristol-Myers Squibb located?▼
Bristol-Myers Squibb operates in the Other sector.
When did Bristol-Myers Squibb complete a stock split?▼
Bristol-Myers Squibb has not had any recent stock splits.